vimarsana.com
Home
Live Updates
Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases : comparemela.com
Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases
- Precision to Receive $17.5 Million in Upfront and Near-Term Payments with Potential for up to $288 Million in Other Development Milestone Payments
- Upfront Cash and Near-Term Payments Expected...
Related Keywords
Michaels Weiss ,
Azercabtagene Zapreleucel ,
Michael Amoroso ,
Precision Biosciences Inc ,
Nasdaq ,
Tg Therapeutics Inc ,
Precision Biosciences ,
Chief Executive Officer ,
Private Securities Litigation Reform Act ,
Quarterly Report ,
Markets ,
comparemela.com © 2020. All Rights Reserved.